Although NF-κB activation leading to increased expression of proinflammatory cytokines in CF epithelial cells has been reported [57–59], our analysis predicted inhibition of NF-κB regulator due to the downregulation of its target genes in CF plasma-induced PBMCs (Fig. 7 c). The gene discussed is NFKB1; the disease is cystic fibrosis.